A Study of A-101 Solution 40% in Subjects With Seborrheic Keratosis.

NCT02667236 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
450
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Aclaris Therapeutics, Inc.